Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Thor

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Oncology Translational Research|May 22, 2018
Metformin Targets Glucose Metabolism in Triple Negative Breast CancerR S Wahdan-Alaswad, S M Edgerton, H S Salem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancersA D Thor, S M Edgerton, S Liu, et al.
American Journal of Clinical Pathology|November 1, 1994
p53 expression in ovarian borderline tumors and stage I carcinomasJ Kupryjańczyk, D A Bell, D W Yandell, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
p53 abnormalities in human parathyroid carcinomaV L Cryns, M P Rubio, A D Thor, et al.
Human Pathology|February 10, 2000
Invasive micropapillary carcinoma of the breast: a prognostic studyM Paterakos, W G Watkin, S M Edgerton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1996
Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal diseaseJ Kupryjanczyk, A D Thor, R Beauchamp, et al.
Human Pathology|April 1, 1995
p53 gene analysis of ovarian borderline tumors and stage I carcinomasJ Kupryjanczyk, D A Bell, D Dimeo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancersS Krajewski, A D Thor, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferationM M Kim, M A Rivera, I L Botchkina, et al.
Cancer Research|February 24, 2001
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosisX H Yang, T L Sladek, X Liu, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Oncology Translational Research|May 22, 2018
Metformin Targets Glucose Metabolism in Triple Negative Breast CancerR S Wahdan-Alaswad, S M Edgerton, H S Salem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancersA D Thor, S M Edgerton, S Liu, et al.
American Journal of Clinical Pathology|November 1, 1994
p53 expression in ovarian borderline tumors and stage I carcinomasJ Kupryjańczyk, D A Bell, D W Yandell, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
p53 abnormalities in human parathyroid carcinomaV L Cryns, M P Rubio, A D Thor, et al.
Human Pathology|February 10, 2000
Invasive micropapillary carcinoma of the breast: a prognostic studyM Paterakos, W G Watkin, S M Edgerton, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 1996
Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal diseaseJ Kupryjanczyk, A D Thor, R Beauchamp, et al.
Human Pathology|April 1, 1995
p53 gene analysis of ovarian borderline tumors and stage I carcinomasJ Kupryjanczyk, D A Bell, D Dimeo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancersS Krajewski, A D Thor, S M Edgerton, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2001
A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferationM M Kim, M A Rivera, I L Botchkina, et al.
Cancer Research|February 24, 2001
Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosisX H Yang, T L Sladek, X Liu, et al.
Pageof 5